Abbott Laboratories Kicks Off Bond Sale for Exact Sciences Deal
Abbott Laboratories is selling corporate bonds in as many as eight parts to help fund its around $21 billion acquisition of cancer-screening company Exact Sciences Corp.
📰 Original Source
Read full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.